UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 148

Sortiert nach

Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway

Blood, 2010-09, Vol.116 (9), p.1574-1584

2010

Volltextzugriff (PDF)

Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival

Blood, 2006-06, Vol.107 (12), p.4807-4816

2006

Volltextzugriff (PDF)

Bolus Versus Prolonged Infusion of Broad-Spectrum Beta-Lactams for Patients with Hematologic Malignancies and High Risk Febrile Neutropenia - a Single Center Prospective Unblinded Randomized Trial

Blood, 2017-12, Vol.130, p.282-282

2017

Volltextzugriff (PDF)

Using Machine Learning Methods to Explore the Role of Non-Coding RNAs in DLBCL

Blood, 2021-11, Vol.138 (Supplement 1), p.4324-4324

2021

Volltextzugriff (PDF)

Quality of Life Is Impaired in Anemic MDS Patients, and May Still Remain Poor Even When Hemoglobin Improves

Blood, 2021-11, Vol.138 (Supplement 1), p.3698-3698

2021

Volltextzugriff (PDF)

Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis

Blood, 2010-12, Vol.116 (24), p.5357-5367

2010

Volltextzugriff (PDF)

A novel role for factor VIII and thrombin/PAR1 in regulating hematopoiesis and its interplay with the bone structure

Blood, 2013-10, Vol.122 (15), p.2562-2571

2013

Volltextzugriff (PDF)

Multiple Myeloma Oligosecretory Relapse, a Non-Negligible Phenomenon. Frequency, Clinical Characteristics and Outcomes in a Single Center

Blood, 2021-11, Vol.138 (Supplement 1), p.3772-3772

2021

Volltextzugriff (PDF)

Antibiotic Stewardship in Patients after Cellular Therapy with Febrile Neutropenia- a Single Center Prospective Unblinded Randomized Trial

Blood, 2021-11, Vol.138 (Supplement 1), p.747-747

2021

Volltextzugriff (PDF)

Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment

Blood, 2006-08, Vol.108 (4), p.1260-1266

2006

Volltextzugriff (PDF)

Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) +/- Daratumumab Treatment Results in Sustained Hematologic Response in Patients with AL Amyloidosis: A Retrospective Analysis of Patients at Mayo Clinic

Blood, 2022-11, Vol.140 (Supplement 1), p.7224-7225

2022

Volltextzugriff (PDF)

Electrocardiogram As a Marker of Cardiac Response in Light Chain Amyloidosis

Blood, 2022-11, Vol.140 (Supplement 1), p.12566-12567

2022

Volltextzugriff (PDF)

Complementary Costimulation of Human T Cell Subpopulations by CD28 and CD81

Blood, 2011-11, Vol.118 (21), p.1124-1124

2011

Volltextzugriff (PDF)

Racial Differences in Nutritional Anemias: Analysis of Folate, Vitamin B12, and Iron Deficiencies

Blood, 2019-11, Vol.134 (Supplement_1), p.3387-3387

2019

Volltextzugriff (PDF)

Going Down the Tubes: A Multidisciplinary Root Cause Analysis on a Patient Safety Event Involving Delayed Transfusions

Blood, 2019-11, Vol.134 (Supplement_1), p.4988-4988

2019

Volltextzugriff (PDF)

Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients

Blood, 2011-08, Vol.118 (5), p.1402-1412

2011

Volltextzugriff (PDF)

Landing disease: a surprising cytological diagnosis on day 2 of life

Blood, 2021-07, Vol.138 (2), p.203-203

2021

Volltextzugriff (PDF)

An Inpatient COVID-19 Prophylaxis Protocol and Its Outcomes: Adherence and Efficacy

Blood, 2021-11, Vol.138 (Supplement 1), p.4267-4267

2021

Volltextzugriff (PDF)

Activated Protein C Induces Stabilization of the Outer Retinal Barrier and Inhibits Laser Induced Choroidal Neovascularization in a Murine Model

Blood, 2018-11, Vol.132 (Supplement 1), p.73-73

2018

Volltextzugriff (PDF)

Deletion of cognate CD8 T cells by immature dendritic cells: a novel role for perforin, granzyme A, TREM-1, and TLR7

Blood, 2012-08, Vol.120 (8), p.1647-1657

2012

Volltextzugriff (PDF)

A Phase II Multicenter Clinical Trial Assessing the Safety and Efficacy of Ixazomib Pomalidomide Dexamethasone Combination As Second or Third-Line Treatment for Patients with Triple Exposed Relapsed and Refractory Multiple Myeloma: Prespecified Interim Analysis (IPoD-790 trial)

Blood, 2022-11, Vol.140 (Supplement 1), p.10131-10132

2022

Volltextzugriff (PDF)

Adolescent and Young Adults with ALL Who Complete Therapy on DFCI Consortium ALL Trials Have Excellent Long-Term Overall Survival

Blood, 2022-11, Vol.140 (Supplement 1), p.8901-8903

2022

Volltextzugriff (PDF)

Body Mass Index Effect on Survival and Toxicities Differs between Age Groups Among Adolescents and Young Adults Treated on DFCI Consortium ALL Trials

Blood, 2022-11, Vol.140 (Supplement 1), p.3164-3165

2022

Volltextzugriff (PDF)

1 – 25 von 148

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBlood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(146)

Publikationsform

Artikel
(148)

Sprache

Englisch
(148)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(34)
Science & Technology
(34)
Hematology
(33)
Humans
(27)
Biological And Medical Sciences
(22)
Animals
(15)
Medical Sciences
(15)
Female
(12)
Hematologic And Hematopoietic Diseases
(11)
Mice
(11)
Cells, Cultured
(9)
Adult
(8)
Fundamental And Applied Biological Sciences. Psychology
(7)
Male
(7)
Middle Aged
(7)
Aged
(5)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(5)
Mice, Inbred C57bl
(5)
Mice, Knockout
(5)
Mutation
(5)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

Journal Of Cell Science
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents

Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway

Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival

Bolus Versus Prolonged Infusion of Broad-Spectrum Beta-Lactams for Patients with Hematologic Malignancies and High Risk Febrile Neutropenia - a Single Center Prospective Unblinded Randomized Trial

Using Machine Learning Methods to Explore the Role of Non-Coding RNAs in DLBCL

Quality of Life Is Impaired in Anemic MDS Patients, and May Still Remain Poor Even When Hemoglobin Improves

Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis

A novel role for factor VIII and thrombin/PAR1 in regulating hematopoiesis and its interplay with the bone structure

Multiple Myeloma Oligosecretory Relapse, a Non-Negligible Phenomenon. Frequency, Clinical Characteristics and Outcomes in a Single Center

Antibiotic Stewardship in Patients after Cellular Therapy with Febrile Neutropenia- a Single Center Prospective Unblinded Randomized Trial

Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment

Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) +/- Daratumumab Treatment Results in Sustained Hematologic Response in Patients with AL Amyloidosis: A Retrospective Analysis of Patients at Mayo Clinic

Electrocardiogram As a Marker of Cardiac Response in Light Chain Amyloidosis

Complementary Costimulation of Human T Cell Subpopulations by CD28 and CD81

Racial Differences in Nutritional Anemias: Analysis of Folate, Vitamin B12, and Iron Deficiencies

Going Down the Tubes: A Multidisciplinary Root Cause Analysis on a Patient Safety Event Involving Delayed Transfusions

Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients

Spectrum of clonal hematopoiesis in VEXAS syndrome

Landing disease: a surprising cytological diagnosis on day 2 of life

An Inpatient COVID-19 Prophylaxis Protocol and Its Outcomes: Adherence and Efficacy

Activated Protein C Induces Stabilization of the Outer Retinal Barrier and Inhibits Laser Induced Choroidal Neovascularization in a Murine Model

Deletion of cognate CD8 T cells by immature dendritic cells: a novel role for perforin, granzyme A, TREM-1, and TLR7

A Phase II Multicenter Clinical Trial Assessing the Safety and Efficacy of Ixazomib Pomalidomide Dexamethasone Combination As Second or Third-Line Treatment for Patients with Triple Exposed Relapsed and Refractory Multiple Myeloma: Prespecified Interim Analysis (IPoD-790 trial)

Adolescent and Young Adults with ALL Who Complete Therapy on DFCI Consortium ALL Trials Have Excellent Long-Term Overall Survival

Body Mass Index Effect on Survival and Toxicities Differs between Age Groups Among Adolescents and Young Adults Treated on DFCI Consortium ALL Trials

Aktive Filter

Suchergebnisse filtern